Life-threatening COVID-19 in a thymoma patient with anti-interferon-α autoantibodies
Neutralizing anti-interferon (IFN)-α autoantibodies can lead to immune dysregulation, potentially resulting in critical coronavirus disease 2019 (COVID-19). We report a case presenting with severe COVID-19 who was subsequently diagnosed to have thymoma and neutralizing anti-IFN-α autoantibodies.
Authors
- Bei‐Chia Guo
- Jann‐Tay Wang (ORCID: https://orcid.org/0000-0002-0924-3469)
- Aristine Cheng (ORCID: https://orcid.org/0000-0002-1182-7375)
- Y. Shih (ORCID: https://orcid.org/0000-0002-5424-1331)
- Wan-Ting Tsai
Institutions
- Taipei City Hospital (TW)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Journal of Microbiology Immunology and Infection
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1016/j.jmii.2025.02.002
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.39